Generics Medicines Initiative:
We have seen a lot of vertical integration in health care, typically different health care providers merging, or providers and health plans. But integration of providers into pharmaceutical manufacturing setting aside a little compounding — is pretty unprecedented.
Well I would say necessity is the mother of invention, right? This is not an ambition that Inter-mountain, nor I suspect the other systems, have had, but as organizations that really try and put our patients at the center of everything we do, some of the issues we’re having around shortages and then secondarily around pricing — they’ve changed the way we’ve thought about things, and so I guess the very few folks in the generic drug industry who are creating these issues, we owe them some thanks because it’s caused us to think creatively.
It’s not how a good market works, and what we aim to do is to create something akin to a public utility that is going to put public good first, and we think we’re going to be successful because we don’t have an inordinate profit motive. We need to make enough margin for this business to be sustainable and to reinvest in it; we are collaborating with general hospitals, NGO, and our prime focus are Govt. approved tenders which has good opportunity for ‘Generics’ medicines supply.
We are also encouraging local distributors in India to create a parallel base for “Generics medicines” sales opportunity; which could help patient in saving money and deciding about monthly health budget, specially for retired people and senior citizens, where diabetic, Alzheimer, blood pressure medicines are necessity to buy on a regular basis.
Hence “Generics Medicines” sales will increase in future; due to many factors not just cost, but general awareness will lead to that.
A generic drug is a medication created to be the same as an existing approved brand-name drug in dosage form, safety, strength, route of administration, quality, and performance characteristics.
Taj Generics is one of the leading generic pharmaceutical company in India. We hold top positions in different established markets worldwide and are building a strong presence in many emerging generics markets. Today, we market more than 500 branded and 4600 generics compositions to consumers in more than 40 countries and territories across the globe.
Labels: priyanka singh taj pharma, taj pharma, taj pharmaceuticals, taj pharmaceuticals news, taj pharmaceuticals director, taj pharmaceuticals reviews, priyanka taj pharma, Priyanka Singh director taj Pharmaceuticals, Priyanka Singh director taj Pharma taj generic, Priyanka singh, taj pharma news, priyanka singh taj, priyanka singh director, Priyanka singh dynamic entrepreneur